Trial Profile
Acute urinary retention risk in BPH patients treated with tamsulosin vs watchful waiting: A 5 year prospective community based study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Apr 2013
Price :
$35
*
At a glance
- Drugs Tamsulosin (Primary)
- Indications Benign prostatic hyperplasia; Lower urinary tract symptoms; Urinary retention
- Focus Therapeutic Use
- 30 Apr 2013 New trial record
- 18 Mar 2013 Results presented at the 28th Congress of the European Association of Urology.